These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6713346)

  • 1. Monocyte-mediated-antibody-dependent cellular cytotoxicity in malignant lymphoma and solid tumors.
    de Mulder PH; de Pauw BE; van de Ven EC; Wagener TD; Haanen C
    Cancer; 1984 Jun; 53(11):2444-9. PubMed ID: 6713346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monocyte cytotoxicity in Hodgkin's disease].
    Pehamberger H; Ludwig H; Pötzi P; Pietschmann H; Knapp W
    Acta Med Austriaca; 1979; 6(5):249-51. PubMed ID: 555222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased monocyte-mediated antibody-dependent cellular cytotoxicity (ADCC) in Hodgkin's disease.
    Pehamberger H; Ludwig H; Pötzi P; Knapp W
    Br J Cancer; 1980 May; 41(5):778-81. PubMed ID: 7426302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased antibody-dependent cytotoxicity mediated by purified monocytes in Hodgkin's disease.
    de Mulder PH; de Pauw BE; Pennings A; Wagener DJ; Haanen C
    Clin Immunol Immunopathol; 1983 Mar; 26(3):406-14. PubMed ID: 6872350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte function in Hodgkin's disease.
    Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
    Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.
    Gupta S; Fernandes G
    Clin Exp Immunol; 1981 Jul; 45(1):205-14. PubMed ID: 6975681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent cell-mediated cytotoxicity in human cancer: characterization of patient leukocyte activity and treatment effects.
    Hersh EV; Murphy SG; Gutterman JU; Morgan J; Quesada J; Zander A; Stewart D
    Cancer; 1982 Jan; 49(2):251-60. PubMed ID: 7032682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte antibody-dependent cellular cytotoxicity in cancer patients.
    De Young NJ; Gill PG
    Cancer Immunol Immunother; 1984; 18(1):54-8. PubMed ID: 6567479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxic activity in patients with Hodgkin disease.
    Láng I; Berényi E; Szegedi G; Török K; Fekete B; Gergely P
    Acta Med Acad Sci Hung; 1977; 34(4):241-5. PubMed ID: 618055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte isolation by flow cytometer-monitored centrifugal elutriation: a preparative tool for antibody-dependent cell-mediated cytotoxicity (ADCC) assays.
    Garner SF; Thomson AR; Lubenko A; Savage J
    Br J Biomed Sci; 1994 Mar; 51(1):35-43. PubMed ID: 7841834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).
    McCarley DL; Shah VO; Weiner RS
    J Immunol; 1983 Oct; 131(4):1780-3. PubMed ID: 6311896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of lymphocyte and monocyte antibody-dependent cellular cytotoxicity by immune complexes: effect of normal human serum.
    Geffner JR; Giordano M; Serebrinsky GP; Palermo MS; Isturiz MA
    Immunol Lett; 1987 Jul; 15(3):255-9. PubMed ID: 2959617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monocyte antibody-dependent cell-mediated cytotoxicity to tumor cells.
    Shaw GM; Levy PC; LoBuglio AF
    J Clin Invest; 1978 Dec; 62(6):1172-80. PubMed ID: 748372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides.
    Kragballe K; Herlin T; Ellegaard J
    Arch Dermatol; 1983 Mar; 119(3):203-6. PubMed ID: 6824357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased monocyte antibody-dependent cell-mediated toxicity in stage I-II malignant melanoma. Augmentation by subcutaneous Corynebacterium parvum.
    Murray JL; Lee ET
    Cancer Immunol Immunother; 1984; 17(1):66-8. PubMed ID: 6563946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
    Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
    J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.